[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-356212-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-356212-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","epidemiological-and-clinical-trends-of-malignant-small-bowel-tumors-in-asia","Epidemiological and clinical trends of malignant small-bowel tumors in Asia","","Malignant small-bowel tumors are rare, comprising under 5% of gastrointestinal cancers, yet incidence is rising in both Western and Asian populations. Expanded diagnostic modalities and improved registry completeness contribute to this upward trend. The review covers adenocarcinoma, neuroendocrine tumors, gastrointestinal stromal tumors, and lymphoma, emphasizing distinct anatomic predilections and clinical behaviors. In Asia, sporadic adenocarcinoma predominates, while Crohn’s disease–associated lesions and small-bowel neuroendocrine tumors are comparatively less common than in Western cohorts. Despite progress in imaging and enteroscopy, nonspecific symptoms and small-bowel inaccessibility delay early detection, yielding generally worse outcomes than in Western series, underscoring the need for region-specific diagnostic strategies and future multicenter research.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/epidemiological-and-clinical-trends-of-malignant-small-bowel-tumors-in-asia/356212/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/epidemiological-and-clinical-trends-of-malignant-small-bowel-tumors-in-asia/356212.png","ImageObject",300,407,{"name":42,"@type":43},"moss~","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-26","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why are malignant small-bowel tumors difficult to detect early?","Question",{"text":63,"@type":64},"Early detection is limited by diagnostic delays from nonspecific symptoms and the small-bowel’s anatomic inaccessibility, which often leads to presentation at advanced stages.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What factors are driving the increasing incidence of malignant small-bowel tumors?",{"text":68,"@type":64},"The rise is attributed to expanded use of advanced diagnostic modalities and improved cancer registry completeness, alongside demographic aging and broader access to evaluation.",{"name":70,"@type":61,"acceptedAnswer":71},"How do clinical outcomes in Asian cohorts compare with Western cohorts?",{"text":72,"@type":64},"Survival outcomes in Asia are generally inferior to those reported in Western cohorts, even though incidence is increasing and diagnostics have improved.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},356212,1790231674,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":115,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},962090895452,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","REVIEW  \nKorean J Intern Med 2026;41 :799-807 [https://doi.org/10.3904/kj](https://doi.org/10.3904/kj)im.2025.422  \nEpidemiological and clinical trends of malignant small-bowel tumors in Asia  \nJung Rock Moon1 and Seong Ran Jeon2  \n1Department of Internal Medicine, Kyung Hee University Hospital at Gangdong, Kyung Hee University School of Medicine, Seoul; 2Department of Internal Medicine, Soonchunhyang University College of Medicine, Seoul, Korea  \nMalignant small-bowel tumors are uncommon, accounting for \u003C 5% of all gastrointestinal cancers, yet their incidence has exhibited a steady rise in both Western and Asian populations. This increase is attributed to expanded use of advanced diagnostic modalities and improved registry completeness. Malignant small-bowel tumors encompass a heterogeneous group—adenocarcinoma, neuroendocrine tumors, gastrointestinal stromal tumors, and lymphoma—each with distinct anatomic predilections, molecular characteristics, and clinical behavior. In Asia, sporadic adenocarcinoma remains the predominant subtype, whereas Crohn’s disease–associated lesions and small-bowel neuroendocrine tumors are relatively less common than in Western cohorts. Early detection continues to be limited by diagnostic delays caused by nonspecific symptoms and the anatomic inaccessibility of the small-bowel. Prognosis varies substantially across subtypes, with adenocarcinoma demonstrating the poorest survival rate despite advances in systemic therapy. Recent nationwide and multicenter studies from Asian countries have highlighted evolving temporal trends, improvements in diagnostic performance, and emerging regional differences in etiology, stage distribution, and outcomes. A clearer understanding of the epidemiologic patterns and clinical char-  \nCopyright © 2026 The Korean Association of Internal Medicine  \nThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ([http://creativecommons.org/licenses/by-nc/4.0/](http://creativecommons.org/licenses/by-nc/4.0/)) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.  \npISSN 1226-3303 eISSN 2005-6648 [http://www.kj](http://www.kj)[im.org](im.org)  \nThe Korean Journal of Internal Medicine Vol. 41, No. 5, September 2026  \nacteristics of malignant small-bowel tumors in Asia is essential for developing region-specific diagnostic strategies, optimizing treatment pathways, and prioritizing areas for future collaborative research.  \nKeywords: Intestine, small; Adenocarcinoma; Neuroendocrine tumor; Gastrointestinal stromal tumor; Lymphoma; Asia; Epidemiology  \nINTRODUCTION  \nAlthough the small-bowel accounts for nearly three quarters of the gastrointestinal (GI) tract in length and more than 90% of its mucosal surface area, malignant tumors arising in this segment represent \u003C 5% of all GI cancers [1-4] . This paradox has historically impeded clinical recognition and epidemiologic characterization, as many cases present at advanced stages owing to nonspecific symptoms and the anatomic inaccessibility of the small-bowel [1] .  \nOver the past two decades, however, malignant small-bowel tumors have been increasingly recognized worldwide. Population-based datasets, including SEER and GLOBOCAN, demonstrate a gradual rise in incidence—from approximately 1.0 to > 2.0 per 100,000—primarily driven by adenocarcinoma and neuroendocrine tumors (NETs) [1,5] . Despite substantial improvements in capsule endoscopy (CE), cross-sectional enterography—including computed tomography enterography (CTE) and magnetic resonance enterography (MRE)—and device-assisted enteroscopy (DAE), most patients continue to present with advanced disease, contributing to poorer outcomes compared with other GI malignancies [2,6] .  \nIn Asia, the clinical and epidemiologic landscape of smallbowel tumors exhibits distinct characteristics. Although incidence is steadily increasing in p","cbCaioK0M7FFfSXp","https://ap.wps.com/l/cbCaioK0M7FFfSXp","pdf",815699,"English","# INTRODUCTION\n# EPIDEMIOLOGY AND TEMPORAL TRENDS","[{\"question\":\"Why are malignant small-bowel tumors difficult to detect early?\",\"answer\":\"Early detection is limited by diagnostic delays from nonspecific symptoms and the small-bowel’s anatomic inaccessibility, which often leads to presentation at advanced stages.\"},{\"question\":\"What factors are driving the increasing incidence of malignant small-bowel tumors?\",\"answer\":\"The rise is attributed to expanded use of advanced diagnostic modalities and improved cancer registry completeness, alongside demographic aging and broader access to evaluation.\"},{\"question\":\"How do clinical outcomes in Asian cohorts compare with Western cohorts?\",\"answer\":\"Survival outcomes in Asia are generally inferior to those reported in Western cohorts, even though incidence is increasing and diagnostics have improved.\"}]","Epidemiological and clinical trends of malignant small-bowel tumors in Asia | PDF",1790124091,23,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/45cb84f1b3469c5abbfbdba91e1d9539.webp",983,1310,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e0693ba51c7c7a4a4176dee5576d7a4a.webp",982,1309,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/53a96fd589215f1ccae80e2421890af9.webp",981,1308,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4440fed4f683e775f5959cee33424dbd.webp",980,1306]